ATH 12.5% 0.4¢ alterity therapeutics limited

SRPT Duchenne Drug trial hits 5 year mark, page-40

  1. 1,640 Posts.
    lightbulb Created with Sketch. 143
    Exactly ITM.

    Moreover AD and HD are terminal conditions associated with late stages of life that are not at all pleasant in how they deal with victims. Im still scratching my head as to how a drug that has so far proven to be safe in trials, that has indicated to be of beneift to patients - with some family representatives writing on this board wanting their family to be back on the medication as they believe they saw improvement- is held up for potential concerns over what happened in dogs over an unknown period of time.

    Surely if the drug can help people from horrible symptoms and death now, its better than potential other symptoms that may come on after prolonged exposure later in life when the patient may have already naturally passed - but they would have passed with better quality of life than had they not been medicated.

    It's a really strange state of play .... and im with wasa on the reasons for it.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(12.5%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.4¢ 0.4¢ 0.4¢ $7.902K 2.037M

Buyers (Bids)

No. Vol. Price($)
40 53603756 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 126995306 20
View Market Depth
Last trade - 14.03pm 15/08/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.